Cargando…
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates
BACKGROUND AND AIMS: LPAR6 is the most recently determined G protein-coupled receptor of lysophosphatidic acid, and hardly any study has demonstrated the performance of LPAR6 in cancers. We sought to clarify the relationship of LPAR6 to prognosis potential and tumor infiltration immune cells in diff...
Autores principales: | He, Jian, Meng, Mei, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845155/ https://www.ncbi.nlm.nih.gov/pubmed/35233377 http://dx.doi.org/10.14218/JCTH.2021.00047 |
Ejemplares similares
-
LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
por: Shi, Jingqi, et al.
Publicado: (2020) -
Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
por: He, Jian, et al.
Publicado: (2021) -
HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Liu, Hui, et al.
Publicado: (2022) -
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
por: Wang, Zhen-Zhen, et al.
Publicado: (2022) -
CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)